FDA Adverse Event Injury Summary report: N

APOGEE 2300 DIGITAL COLOR DOPPLER ULTRASOUND IMAGING SYSTEM

MDR report key: 22324791 · Received June 24, 2025

Report

Report Number
3012977056-2025-00185
Event Type
Injury
Date Received
June 24, 2025
Date of Event
June 13, 2025
Report Date
July 1, 2025
Manufacturer
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO. LT
Product Code
IYN
UDI-DI
06938396423001
Adverse Event
Yes
Report Source
Distributor report
Reporter Location
AZ, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

PROCEPT BIOROBOTICS IS AN IMPORTER OF THE APOGEE 2300 DIGITAL COLOR DOPPLER ULTRASOUND IMAGING SYSTEM. THE RECEIVING INSPECTION RECORD FOR THE APOGEE 2300 DIGITAL COLOR DOPPLER ULTRASOUND IMAGING SYSTEM SERIAL NUMBER (B)(6) WAS REVIEWED. IT PASSED THE RECEIVING INSPECTION. NO REWORKS WERE PERFORMED BY PROCEPT BIOROBOTICS THAT WERE RELATED TO THE REPORTED EVENT. THE REVIEW INDICATED THAT THE DEVICE MET SPECIFICATIONS WHEN RELEASED FOR DISTRIBUTION. THE REVIEW OF THE OPERATION MANUAL FOR THE APOGEE 2300 DEVICE (IFU) FOUND THAT IT HAS COVERED THE RELATED SAFETY INSTRUCTION: 1.6 SAFETY L) WHEN PERFORMING THE RECTAL ULTRASOUND EXAM, BE GENTLE IN THE MOVEMENT. DO NOT PERFORM VIOLENT OPERATION, OTHERWISE IT MAY CAUSE RISKS OF PERFORATION OF THE RECTAL WALL, DAMAGE TO THE ANUS AND PERIANAL TISSUES, DAMAGE TO THE RECTAL MUCOSA OR BLEEDING. IN SUMMARY, THE ROOT CAUSE FOR THE REPORTED EVENT COULD NOT BE DETERMINED. THE USER MANUAL OF THE APOGEE 2300 DEVICE LISTS RECTAL PERFORATION AS A POTENTIAL RISK OF THE PROCEDURE. BASED ON THE REVIEW OF TREATMENT LOG FILES, DHR, POST-MARKETING DATA AND IFU, THE EVENT IS CONSIDERED NOT TO BE DEVICE RELATED. THE INFORMATION RECEIVED DETERMINED THAT THE RECTAL PERFORATION WAS NOT RELATED TO THE SIUI APOGEE 2300 DEVICE. SUBMISSION OF THIS REPORT DOES NOT CONSTITUTE AN ADMISSION THAT THE MANUFACTURER'S PRODUCT CAUSED OR CONTRIBUTED TO THE EVENT. CORRECTED DATA: THE UDI ((B)(4) INCLUDED IN THE INITIAL REPORT BELONGS TO SIUI ECBP-1 TRUS PROBE FOR ULTRASOUND. THE UDI FOR APOGEE 2300 ULTRASOUND SYSTEM IS (B)(4).

Description of Event or Problem · 0

A MALE PATIENT UNDERWENT AQUABLATION THERAPY FOR SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH). PROCEPT BIOROBOTICS CORPORATION (PROCEPT) BECAME AWARE OF A RECTAL MUCOSAL TEAR WITH THE APOGEE 2300 DIGITAL COLOR DOPPLER ULTRASOUND IMAGING SYSTEM AND ITS ASSOCIATED ECBP-1 TRUS PROBE. THE TREATING SURGEON REPORTED THAT BLEEDING WAS NOTED AFTER ECBP-1 TRUS PROBE INSERTION. THE TREATING SURGEON DID A RECTAL EXAM POST ECBP-1 TRUS PROBE REMOVAL AND NOTED SMALL EXTERNAL MUCOSAL TEAR NEAR ANUS. THE TREATING SURGEON NOTED NO ISSUES WHEN DOING AN INTERNAL RECTAL FINGER SWEEP. NO ADDITIONAL INTERVENTIONS OR CARE WERE NEEDED. THE TREATING SURGEON IS UNSURE WHY THERE WAS A SMALL MUCOSAL TEAR, AS NO RESISTANCE WAS ENCOUNTERED WHEN ENTERING THE PATIENT (SUSPECTED IT COULD BE DUE TO THE PATIENT BEING OLDER AND HAVING FRAGILE SKIN). THE TREATING SURGEON WILL BE SEEING THE PATIENT IN 2 WEEKS FOR A FOLLOW-UP. NO MALFUNCTION OF THE APOGEE 2300 DIGITAL COLOR DOPPLER ULTRASOUND IMAGING SYSTEM AND ASSOCIATED COMPONENT ECBP-1 TRUS PROBE WERE REPORTED DURING THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1607782 APOGEE 2300 DIGITAL COLOR DOPPLER ULTRASOUND IMAGING SYSTEM ULTRASONIC PULSED DOPPLER IMAGING SYSTEM IYN SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO. LT 06938396423001

Patients

Seq Age Sex Outcome Treatment
1 NA Male Other